Your browser doesn't support javascript.
loading
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
Nyberg, Tommy; Ferguson, Neil M; Nash, Sophie G; Webster, Harriet H; Flaxman, Seth; Andrews, Nick; Hinsley, Wes; Bernal, Jamie Lopez; Kall, Meaghan; Bhatt, Samir; Blomquist, Paula; Zaidi, Asad; Volz, Erik; Aziz, Nurin Abdul; Harman, Katie; Funk, Sebastian; Abbott, Sam; Hope, Russell; Charlett, Andre; Chand, Meera; Ghani, Azra C; Seaman, Shaun R; Dabrera, Gavin; De Angelis, Daniela; Presanis, Anne M; Thelwall, Simon.
Afiliação
  • Nyberg T; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK. Electronic address: tommy.nyberg@mrc-bsu.cam.ac.uk.
  • Ferguson NM; NIHR Health Protection Research Unit for Modelling and Health Economics, MRC Centre for Global Infectious Disease Analysis, Jameel Institute, Imperial College London, London, UK. Electronic address: neil.ferguson@imperial.ac.uk.
  • Nash SG; COVID-19 National Epidemiology Cell, UK Health Security Agency, London, UK.
  • Webster HH; COVID-19 National Epidemiology Cell, UK Health Security Agency, London, UK.
  • Flaxman S; Department of Computer Science, University of Oxford, Oxford, UK.
  • Andrews N; COVID-19 Surveillance Cell, UK Health Security Agency, London, UK.
  • Hinsley W; NIHR Health Protection Research Unit for Modelling and Health Economics, MRC Centre for Global Infectious Disease Analysis, Jameel Institute, Imperial College London, London, UK.
  • Bernal JL; NIHR Health Protection Research Unit for Respiratory Infections, Imperial College London, London, UK; COVID-19 Surveillance Cell, UK Health Security Agency, London, UK.
  • Kall M; COVID-19 National Epidemiology Cell, UK Health Security Agency, London, UK.
  • Bhatt S; NIHR Health Protection Research Unit for Modelling and Health Economics, MRC Centre for Global Infectious Disease Analysis, Jameel Institute, Imperial College London, London, UK.
  • Blomquist P; Outbreak Surveillance Team, UK Health Security Agency, London, UK.
  • Zaidi A; COVID-19 National Epidemiology Cell, UK Health Security Agency, London, UK.
  • Volz E; NIHR Health Protection Research Unit for Modelling and Health Economics, MRC Centre for Global Infectious Disease Analysis, Jameel Institute, Imperial College London, London, UK.
  • Aziz NA; COVID-19 National Epidemiology Cell, UK Health Security Agency, London, UK.
  • Harman K; COVID-19 National Epidemiology Cell, UK Health Security Agency, London, UK.
  • Funk S; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK.
  • Abbott S; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK.
  • Hope R; COVID-19 National Epidemiology Cell, UK Health Security Agency, London, UK.
  • Charlett A; NIHR Health Protection Research Unit for Modelling and Health Economics, MRC Centre for Global Infectious Disease Analysis, Jameel Institute, Imperial College London, London, UK; Statistics, Modelling and Economics Department, UK Health Security Agency, London, UK; Joint Modelling Team, UK Health Se
  • Chand M; COVID-19 Genomics Cell, UK Health Security Agency, London, UK.
  • Ghani AC; NIHR Health Protection Research Unit for Modelling and Health Economics, MRC Centre for Global Infectious Disease Analysis, Jameel Institute, Imperial College London, London, UK.
  • Seaman SR; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
  • Dabrera G; COVID-19 National Epidemiology Cell, UK Health Security Agency, London, UK.
  • De Angelis D; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK; Statistics, Modelling and Economics Department, UK Health Security Agency, London, UK; Joint Modelling Team, UK Health Security Agency, London, UK; NIHR Health Protection Research Unit for Behavioural Science and Evaluation at the Unive
  • Presanis AM; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
  • Thelwall S; COVID-19 National Epidemiology Cell, UK Health Security Agency, London, UK.
Lancet ; 399(10332): 1303-1312, 2022 04 02.
Article em En | MEDLINE | ID: mdl-35305296
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Lancet Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Lancet Ano de publicação: 2022 Tipo de documento: Article